Liver kinase B1 (LKB1) staves off γδ T-cell-mediated autoimmune liver disease

Cell Mol Immunol. 2024 Jun;21(6):641-642. doi: 10.1038/s41423-024-01172-8. Epub 2024 May 16.

Authors

Yiwen Wang¹, Lan Wu¹, Luc Van Kaer²

Affiliations

¹ Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN, USA.
² Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN, USA. luc.van.kaer@vanderbilt.edu.

PMID: 38755457
PMCID: PMC11143180 (available on 2025-06-01)
DOI: 10.1038/s41423-024-01172-8

No abstract available

Publication types

Letter

MeSH terms

AMP-Activated Protein Kinases / metabolism
Animals
Autoimmune Diseases* / immunology
Humans
Liver Diseases / immunology
Mice
Protein Serine-Threonine Kinases* / genetics
Protein Serine-Threonine Kinases* / metabolism
Receptors, Antigen, T-Cell, gamma-delta* / immunology
Receptors, Antigen, T-Cell, gamma-delta* / metabolism
T-Lymphocytes / immunology

Substances

Receptors, Antigen, T-Cell, gamma-delta
Protein Serine-Threonine Kinases
Stk11 protein, mouse
AMP-Activated Protein Kinases

Grants and funding